Please join us at the 24th International Pathogenic Neisseria Conference (IPNC) in Florence, Italy, March 30–April 4, 2025.
We’re excited to connect with global leaders in the Neisseria research community to learn how we can continue supporting your work, including meningococcal and gonococcal vaccine development.
Our biological reagents, including antibody-depleted human complement (ADHC) and sera (ADHS), are available in large lots (>5 L) to streamline every stage of vaccine R&D—from immunogenicity assays to high-throughput clinical testing.
Interested in meeting at IPNC? Contact us to schedule a time—we’d love to hear about your research!
